Connect with us
Information

NORTH AMERICA EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

NORTH AMERICA EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

phase 2 clinical study

POPULAR ARTICLES

Novan’s Phase 2 SB206 Study Published in Journal of American Academy of Dermatology

vTv Therapeutics Presents Additional Positive Data from the Phase 2 Simplici-T1 Study

pharmaceutical investing

Progenics Pharmaceuticals Doses First Patient in Phase 2 Clinical Study of 1095 Radiotherapy

LATEST ARTICLES

Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy

pharmaceutical investing

Cytokinetics Reports First Quarter 2018 Financial Results

Theralase Shows New Stability of Lead Cancer Drug

pharmaceutical investing

VistaGen Gets FDA Approval to Begin Study of AV-101

pharmaceutical investing

Kalytera Therapeutics Posts Q2 Financial Results

pharmaceutical investing

Corbus Presents Data from Study of Anabasum

pharmaceutical investing

Revive Therapeutics Gives Corporate Update

Latest News

Operational Update

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Charbone Hydrogen Announces Closing of Units for Debt Financing for a Total Amount of $1.3M

Charbone Hydrogene Annonce un Financement de Reglements de Dettes par Emission d'Unites pour un Montant Total de 1,3M$

Halcones Precious Metals Provides Update on Polaris Gold Project, Antofagasta Region Chile